Nexentis Technologies Inc. (NXTS) stock
NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.82−0.17 (-8.42%)
Close on Nov 17, 2026Market cap $2.65MP/E –Yield –
Nexentis Technologies cash
Cash and short-term investments held at the end of each period.
Nexentis Technologies's cash was $8.88M at Jun 30, 2026. For fiscal 2025 it was $4.07M, up 61.8% from the year before. The highest annual figure on record is $6.75M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.07M | +61.8% |
| FY2024 | Dec 31, 2024 | $2.52M | -43.8% |
| FY2023 | Dec 31, 2023 | $4.48M | -22.1% |
| FY2022 | Dec 31, 2022 | $5.75M | -14.8% |
| FY2021 | Dec 31, 2021 | $6.75M | +2679.3% |
| FY2020 | Dec 31, 2020 | $242.90K | -16.5% |
| FY2019 | Dec 31, 2019 | $290.82K | -33.9% |
| FY2018 | Dec 31, 2018 | $439.81K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.88M | +158.6% |
| Q1 FY2026 | Mar 31, 2026 | $6.20M | +108.3% |
| Q4 FY2025 | Dec 31, 2025 | $4.07M | +61.8% |
| Q3 FY2025 | Sep 30, 2025 | $6.28M | +126.6% |
| Q2 FY2025 | Jun 30, 2025 | $3.43M | -23.5% |
| Q1 FY2025 | Mar 31, 2025 | $2.98M | -15.3% |
| Q4 FY2024 | Dec 31, 2024 | $2.52M | -43.8% |
| Q3 FY2024 | Sep 30, 2024 | $2.77M | +40.0% |
| Q2 FY2024 | Jun 30, 2024 | $4.49M | +48.8% |
| Q1 FY2024 | Mar 31, 2024 | $3.51M | -23.6% |
| Q4 FY2023 | Dec 31, 2023 | $4.48M | -22.1% |
| Q3 FY2023 | Sep 30, 2023 | $1.98M | -70.4% |
| Q2 FY2023 | Jun 30, 2023 | $3.02M | -31.1% |
| Q1 FY2023 | Mar 31, 2023 | $4.60M | -18.6% |
| Q4 FY2022 | Dec 31, 2022 | $5.75M | -14.8% |
| Q3 FY2022 | Sep 30, 2022 | $6.69M | -13.9% |
| Q2 FY2022 | Jun 30, 2022 | $4.38M | -52.9% |
| Q1 FY2022 | Mar 31, 2022 | $5.64M | +1425.2% |
| Q4 FY2021 | Dec 31, 2021 | $6.75M | +2679.3% |
| Q3 FY2021 | Sep 30, 2021 | $7.77M | +2402.3% |
| Q2 FY2021 | Jun 30, 2021 | $9.31M | +26298.7% |
| Q1 FY2021 | Mar 31, 2021 | $370.07K | +105.6% |
| Q4 FY2020 | Dec 31, 2020 | $242.90K | -16.5% |
| Q3 FY2020 | Sep 30, 2020 | $310.57K | -29.4% |
| Q2 FY2020 | Jun 30, 2020 | $35.25K | – |
| Q1 FY2020 | Mar 31, 2020 | $180.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $290.82K | – |
| Q4 FY2018 | Dec 31, 2018 | $439.81K | – |
See a number that looks wrong?